A Phase 1, Open-label, 2-period, Fixed Sequence, Cross-over Study To Investigate The Effect Of Multiple Doses Of Rifampicin Or Itraconazole On The Pharmacokinetics Of Single Dose Ensartinib In Healthy Volunteers.
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Ensartinib (Primary) ; Itraconazole; Rifampicin
- Indications CNS cancer; Malignant melanoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Betta Pharmaceuticals Co Ltd
Most Recent Events
- 17 Jul 2024 New trial record